Continuous Flow Ventilation With the Ventijet System in Acute Respiratory Distress Syndrome: a First-in-Human Feasibility and Non-Inferiority Trial

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

December 16, 2022

Study Completion Date

March 16, 2023

Conditions
ARDSMechanical VentilationHypoxemic Respiratory Failure
Interventions
DEVICE

VENTIJET system

The Ventijet system is an investigational ventilation device delivering continuous high-velocity gas flow through a proximal nozzle. The system is designed to maintain alveolar recruitment with low driving pressures, acting as an expiratory brake. Patients received continuous flow ventilation using Ventijet for 1 to 24 hours after baseline assessment with conventional mechanical ventilation.

Trial Locations (1)

08003

Hospital del Mar, Barcelona

All Listed Sponsors
collaborator

Hospital del Mar Research Institute (IMIM)

OTHER

lead

Hospital del Mar

OTHER